controlled study Article 5 nonhuman 4 unclassified drug 4 proton nuclear magnetic resonance 3 IC50 2 adult 2 antibacterial activity 2 diabetes mellitus 2 drug synthesis 2 human 2 male 2 mass spectrometry 2 minimum inhibitory concentration 2 molecular docking 2 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (2 hydroxybenzylidene)piperidin 4 carbohydrazide 1 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (2 nitrobenzylidene)piperidin 4 carbohydrazide 1 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (2,4 dichlorobenzylidene)piperidin 4 carbohydrazide 1 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (3 nitrobenzylidene)piperidin 4 carbohydrazide 1 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (3,4 dimethoxybenzylidene)piperidin 4 carbohydrazide 1 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (4 dimethylamino)benzylidene)piperidin 4 carbohydrazide 1 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (4 hydroxybenzylidene)piperidin 4 carbohydrazide 1 1 (3,5 dichloro 2 ethoxyphenylsulfonyl) N (4 methoxybenzylidene)piperidin 4 carbohydrazide 1 1 [(3,5 dichloro 2 ethoxyphenylsulfonyl] piperidin 4 carbohydrazide 1 2 [(5 (aralkyl/aryl1,3,4 oxadiazol 2 yl)sulfanyl] n (4 methyl 1,3 thiazol 2 yl) acetamide 1 2 [(5 benzyl 1,3,4 oxadiazol 2 yl)sulfanyl] n (4 methyl 1,3 thiazol 2 yl)acetamide 1 2 [[5 (2 chloro 3,5 dinitrophenyl) 1,3,4 oxadiazol 2 yl]sulfanyl] n (4 methyl 1,3 thiazol 2 yl)acetamide 1 2 [[5 (2 chlorophenyl) 1,3,4 oxadiazol 2 yl]sulfanyl] n (4 methyl 1,3 thiazol 2 yl)acetamide 1 2 [[5 (2 methoxyphenyl) 1,3,4 oxadiazol 2 yl]sulfanyl] n (4 methyl 1,3 thiazol 2 yl)acetamide 1 2 [[5 (2 methyl 3,5 dinitrophenyl) 1,3,4 oxadiazol 2 yl]sulfanyl] n (4 methyl 1,3 thiazol 2 yl)acetamide 1